Emcure Pharmaceuticals Ltd Publishes Financial Information
Robust Product Portfolio
Announcement Summary
EMCURE PHARMACEUTICALS LIMITED has released its financial information for the fiscal year ending on March 31. The company's operations emphasize developing a diversified product portfolio, including innovative drug delivery systems.
Emcure's global financial information includes:
- Emcure UK INR Converted Financials FY 2024
- Marcan INR Converted Finacials FY 2024
- Tillomed UK INR Converted Financial FY 2024
Lawsuit Update
Additionally, the company acknowledged the lawsuit filed against it in the United States District Court Seattle Division by HDT Bio Corp.
تعليقات